Tag

Glucosamine

All articles tagged with #glucosamine

Glucosamine Linked to Faster Dementia Progression in New Study
health11 days ago

Glucosamine Linked to Faster Dementia Progression in New Study

A new study from the University of Florida suggests that glucosamine, a common over-the-counter joint supplement, may accelerate cognitive decline in individuals with Alzheimer’s disease or mild cognitive impairment. Researchers found that glucosamine use is associated with a 25% higher risk of progressing to dementia and increased mortality in dementia patients. The study links this to 'hyperglycosylation,' an overactive sugar-tagging process in the brain, though it notes that observational data cannot prove causality and calls for clinical trials.

Glucosamine Linked to 25% Higher Dementia Progression Risk in Cognitive Impairment Patients
health12 days ago

Glucosamine Linked to 25% Higher Dementia Progression Risk in Cognitive Impairment Patients

A University of Florida study published in Nature Metabolism finds that glucosamine use is associated with a 25% higher risk of progression from mild cognitive impairment to dementia. The research suggests the supplement may disrupt glycosylation, a process where sugar chains attach to proteins, potentially interfering with nerve cell communication in brains already affected by Alzheimer's-like changes. While observational data cannot prove causality, the findings highlight a potential safety signal for individuals with existing cognitive issues.

New Data Suggests Glucosamine May Accelerate Dementia in Early Cognitive Decline
health-and-science13 days ago

New Data Suggests Glucosamine May Accelerate Dementia in Early Cognitive Decline

A new study published in Nature Metabolism indicates that glucosamine, a widely used joint supplement, is associated with a 25% higher risk of progression from mild cognitive impairment to dementia. Researchers at the University of Florida found that the supplement may exacerbate abnormal sugar-tagging processes in the brain, though causality remains unproven.

New Study Links Common Joint Supplement Glucosamine to Faster Alzheimer's Progression
health-and-medicine20 days ago

New Study Links Common Joint Supplement Glucosamine to Faster Alzheimer's Progression

A University of Florida study published in Nature Metabolism finds that glucosamine use is associated with a 25% higher risk of mild cognitive impairment progressing to dementia. While lab tests suggest the supplement may worsen abnormal sugar-tagging in the brain, researchers emphasize that observational data cannot prove causality and that clinical trials are required.

New Studies Question If Common Supplements Protect or Harm Aging Brains
health1 month ago

New Studies Question If Common Supplements Protect or Harm Aging Brains

Recent observational studies suggest that popular supplements like vitamin D, fish oil, and glucosamine may be associated with faster cognitive decline in older adults, contradicting their reputation as brain-protecting. While no federal agency has issued warnings, experts urge caution, noting that these active compounds may behave differently in aging brains. The findings are preliminary and do not prove causation, but they highlight the need for age-specific dosing guidance and medical review for seniors taking multiple supplements.

Glucosamine Linked to Faster Dementia Progression in MCI and Higher Mortality in Dementia
health3 months ago

Glucosamine Linked to Faster Dementia Progression in MCI and Higher Mortality in Dementia

A UF Health AI-assisted study published in Nature Metabolism analyzed records from 2012–2024 (over 50,000 patients with dementia or MCI). It found that about 8% used glucosamine and, among those with MCI, users were 25% more likely to progress to dementia, while among patients with dementia, use was linked to a 25% higher risk of death. The authors caution this is associative, not causal, and call for controlled trials. Glucosamine can cross the blood–brain barrier and may influence protein sugar-tagging in Alzheimer’s brains. If you have dementia or MCI and take glucosamine, discuss alternatives with a clinician; healthy adults face no immediate alarm.

Glucosamine May Accelerate Alzheimer’s Decline and Increase Mortality Risk
health3 months ago

Glucosamine May Accelerate Alzheimer’s Decline and Increase Mortality Risk

A Nature Metabolism study finds that glucosamine, a widely used joint-pain supplement, is associated with a 25% higher five-year mortality and faster progression of Alzheimer’s disease and mild cognitive impairment; mice with Alzheimer’s-like symptoms also showed memory decline after glucosamine administration. Researchers stress this is an association, not causation, and suggest arthritis pain could partly explain the link, while other research hints glucosamine may relate to lower overall mortality; scientists are exploring sugar-blocking approaches to potentially slow dementia.

Glucosamine may accelerate dementia progression, study finds
health4 months ago

Glucosamine may accelerate dementia progression, study finds

New research links glucosamine, a common osteoarthritis supplement, to faster dementia progression. In mice, glucosamine increased brain glycan production and worsened memory; in humans, ADRD patients who used glucosamine had about a 25% higher mortality risk over about 5 years, while those with milder cognitive impairment showed no mortality increase. Researchers caution that findings are not proof of causation and call for more studies before changing supplement guidance.

Glucosamine may accelerate memory loss in early Alzheimer's, study suggests
health4 months ago

Glucosamine may accelerate memory loss in early Alzheimer's, study suggests

A Nature Metabolism study of UF Health records (24k dementia, 41k MCI) links glucosamine use to 25% higher five-year mortality and faster progression from MCI to Alzheimer's; mouse experiments suggest a brain sugar-processing mechanism, with glucosamine worsening memory and enzyme blockers improving symptoms. The authors warn this shows association, not causation, and urge further trials.

Common Joint Supplement Glucosamine May Speed Dementia Progression, UF Study Finds
health4 months ago

Common Joint Supplement Glucosamine May Speed Dementia Progression, UF Study Finds

UF researchers analyzed deidentified health records (2012–2024) and mouse/human brain data and found glucosamine use among people with mild cognitive impairment was linked to about a 25% higher odds of progressing to dementia, and higher mortality risk in those already with dementia. They identify an overactive brain sugar-tagging (glycosylation) pathway as a potential mechanism, suggesting metabolism as a treatment target, but causality is not proven and clinical trials are needed.

Glucosamine May Be Linked to Faster Dementia Progression, Study Finds
health4 months ago

Glucosamine May Be Linked to Faster Dementia Progression, Study Finds

A study using anonymized UF Health records of about 24,000 dementia patients and 41,000 with mild cognitive impairment found glucosamine use associated with a 25% higher risk of death within five years for Alzheimer's patients and a 25% higher likelihood of progression from MCI to Alzheimer's. Mouse experiments suggested a mechanism involving brain sugar chains, but the study shows association, not causation, and dose, brand, and duration are unknown. The findings warrant caution for people with cognitive decline and call for controlled trials to establish causality.

Glucosamine use linked to quicker cognitive decline in Alzheimer's patients, study finds
health4 months ago

Glucosamine use linked to quicker cognitive decline in Alzheimer's patients, study finds

An observational study from the University of Florida analyzed patient records and found that people with Alzheimer’s who took glucosamine—a common joint supplement—were about 25% more likely to die within five years than those who didn’t use it. The researchers emphasize the association, not causation, and say a clinical trial is needed to determine if glucosamine contributes to faster cognitive decline. They note that glucosamine might be harmful in brains already experiencing decline but could be safe or even protective in healthy brains; more research is needed on dosage, brands, and patient context.

Glucosamine Use May Accelerate Alzheimer’s Progression, UF Study Finds
health-and-medicine4 months ago

Glucosamine Use May Accelerate Alzheimer’s Progression, UF Study Finds

UF Health analyzed records from 2012–2024 plus brain tissue and mouse studies and found glucosamine use associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia and a 25% higher mortality in Alzheimer's disease patients. The research points to a hyperactive protein sugar-tagging (glycosylation) pathway as a potential mechanism, suggesting metabolic dysfunction may drive progression, though causality isn’t proven and clinical trials are needed.